Device type · QBJ
Integrated Continuous Glucose Monitoring System, Factory Calibrated
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QBJ
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
18
510(k), De Novo and PMA
Adverse event reports
636,709
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Integrated Continuous Glucose Monitoring System, Factory Calibrated
- Product code
- QBJ
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1355
- FDA record
- Classification database entry for QBJ
Latest FDA decisions
The 8 newest of 18 since 2015.
- Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System510(k)
K261402 · Decided Jun 8, 2026 · 40 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ) · Laboratory Medicine & Pathology
K253737 · Decided Feb 3, 2026 · 71 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ) · Laboratory Medicine & Pathology
K253710 · Decided Dec 17, 2025 · 23 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ) · Laboratory Medicine & Pathology
K243214 · Decided Apr 9, 2025 · 188 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ) · Laboratory Medicine & Pathology
K233537 · Decided Apr 23, 2024 · 172 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ) · Laboratory Medicine & Pathology
K240902 · Decided Apr 23, 2024 · 21 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ) · Laboratory Medicine & Pathology
K234133 · Decided Feb 26, 2024 · 59 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ) · Laboratory Medicine & Pathology
K231081 · Decided May 15, 2023 · 28 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ) · Laboratory Medicine & Pathology
Reports received
636,709
Received Nov 1, 2025 to Nov 19, 2026. Includes 559 of another or unstated type.
Malfunction reports
617,141
97% of reports
Injury reports
18,855
3.0% of reports
Death reports
154
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 23,260 | 382 | 0 | 1 |
| Jan 24 | 27,375 | 539 | 1 | 0 |
| Feb 24 | 23,591 | 491 | 1 | 0 |
| Mar 24 | 22,816 | 515 | 2 | 0 |
| Apr 24 | 26,619 | 545 | 2 | 0 |
| May 24 | 28,330 | 596 | 2 | 0 |
| Jun 24 | 24,941 | 734 | 5 | 0 |
| Jul 24 | 33,836 | 710 | 1 | 1 |
| Aug 24 | 32,622 | 725 | 1 | 2 |
| Sep 24 | 30,391 | 846 | 4 | 2 |
| Oct 24 | 32,156 | 782 | 2 | 1 |
| Nov 24 | 29,449 | 634 | 1 | 1 |
| Dec 24 | 27,151 | 688 | 3 | 3 |
| Jan 25 | 28,250 | 753 | 6 | 0 |
| Feb 25 | 21,704 | 757 | 4 | 0 |
| Mar 25 | 26,752 | 759 | 1 | 0 |
| Apr 25 | 28,572 | 779 | 2 | 0 |
| May 25 | 32,679 | 941 | 0 | 3 |
| Jun 25 | 33,649 | 943 | 5 | 2 |
| Jul 25 | 40,188 | 1,163 | 7 | 4 |
| Aug 25 | 37,367 | 1,116 | 9 | 2 |
| Sep 25 | 34,977 | 1,088 | 7 | 7 |
| Oct 25 | 34,132 | 1,107 | 6 | 1 |
| Nov 25 | 23,245 | 1,015 | 14 | 0 |
| Dec 25 | 26,379 | 1,475 | 20 | 0 |
| Jan 26 | 82,421 | 1,280 | 25 | 5 |
| Feb 26 | 21,874 | 1,398 | 13 | 0 |
| Mar 26 | 27,589 | 1,330 | 14 | 2 |
| Apr 26 | 52,802 | 1,781 | 4 | 0 |
| May 26 | 57,186 | 1,845 | 9 | 0 |
| Jun 26 | 65,787 | 1,789 | 14 | 0 |
| Jul 26 | 48,681 | 1,930 | 11 | 55 |
| Aug 26 | 92,354 | 1,651 | 13 | 122 |
| Sep 26 | 81,854 | 1,888 | 6 | 140 |
| Oct 26 | 36,969 | 1,473 | 11 | 235 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Incorrect, Inadequate or Imprecise Result or Readings182,154
- Low Readings148,670
- Wireless Communication Problem114,873
- Protective Measures Problem58,846
- Detachment of Device or Device Component27,958
- High Readings13,676
- Appropriate Device Problem Term/Code Not Available12,467
- No Device Output12,094
- Device Alarm System11,962
- Unintended Application Program Shut Down10,172
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions555,948
- Hyperglycemia49,785
- Hypoglycemia13,376
- Device Embedded In Tissue or Plaque5,769
- Foreign Body In Patient3,609
- Loss of consciousness3,444
- Dizziness2,159
- Insufficient Information2,112
- Vomiting1,621
- Elevated Ketones/ Diabetic Ketoacidosis1,618
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2574-2026 · Started May 27, 2026 · Posted by FDA Jun 24, 2026
Reason given: Certain lots of Dexcom G7 sensors originally designated as scrap and intended for destruction were stolen during the destruction process. The sensors were later sold to pharmacies and distributors by Pharmsource, LLC. Lot 1725204004 were designated for destruction because the G7 sensors were not properly sterilized...
Cause as FDA categorized it: Nonconforming Material/Component
Z-2163-2026 · Started Apr 14, 2026 · Posted by FDA May 11, 2026
Reason given: A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV notifications may queue up and then "replay" sequentially when the user brings the app to the...
Cause as FDA categorized it: Software design
Z-2164-2026 · Started Apr 14, 2026 · Posted by FDA May 11, 2026
Reason given: A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV notifications may queue up and then "replay" sequentially when the user brings the app to the...
Cause as FDA categorized it: Software design
Z-2165-2026 · Started Apr 14, 2026 · Posted by FDA May 11, 2026
Reason given: A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV notifications may queue up and then "replay" sequentially when the user brings the app to the...
Cause as FDA categorized it: Software design
- Continuous Glucose Monitor (CGM)Open, Classified
Z-0770-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025
Reason given: Distribution without premarket approval/clearance.
Cause as FDA categorized it: No Marketing Application
Z-0318-2026 · Started Aug 28, 2025 · Posted by FDA Oct 30, 2025
Reason given: A software defect in version v1.15.0 of the G6 Android app can cause the app to terminate unexpectedly, which may result in the user not receiving estimated glucose values, alarms, alerts or notifications. This could result in the missed detection of a hyperglycemic or hypoglycemic event, protentional resulting in...
Cause as FDA categorized it: Software Design Change
Z-2446-2025 · Started Jul 24, 2025 · Posted by FDA Sep 4, 2025
Reason given: The affected devices are the Dexcom G7 Continuous Glucose Monitoring System (CGM System) using iOS, watchOS and Android App software (versions 2.8.0 or earlier) and Dexcom ONE+ CGM System using iOS and Android App software (versions 1.4.0 or earlier), henceforth referred to as the App. The affected App does not...
Cause as FDA categorized it: Software design
Z-2447-2025 · Started Jul 24, 2025 · Posted by FDA Sep 4, 2025
Reason given: The affected devices are the Dexcom G7 Continuous Glucose Monitoring System (CGM System) using iOS, watchOS and Android App software (versions 2.8.0 or earlier) and Dexcom ONE+ CGM System using iOS and Android App software (versions 1.4.0 or earlier), henceforth referred to as the App. The affected App does not...
Cause as FDA categorized it: Software design
Showing the 8 newest of 23 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.